KCTD17 Gene DYT26 Myoclonic NGS Genetic DNA Test
Comprehensive Genetic Testing for Myoclonic Dystonia
The KCTD17 Gene DYT26 Myoclonic NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations responsible for DYT26 myoclonic dystonia. This advanced testing methodology provides crucial insights for patients and healthcare providers managing complex movement disorders.
What This Test Measures and Detects
This specialized genetic test focuses on identifying mutations within the KCTD17 gene, which has been scientifically linked to DYT26 myoclonic dystonia. The test utilizes state-of-the-art Next-Generation Sequencing (NGS) technology to analyze the entire coding region of the KCTD17 gene, detecting:
- Point mutations and single nucleotide variants
- Small insertions and deletions
- Copy number variations affecting the KCTD17 gene
- Pathogenic variants associated with autosomal dominant inheritance patterns
Who Should Consider This Test
This genetic test is particularly recommended for individuals experiencing:
- Unexplained myoclonic jerks or muscle twitches
- Dystonic movements affecting specific body regions
- Family history of movement disorders or dystonia
- Early-onset movement symptoms without clear diagnosis
- Progressive neurological symptoms resembling myoclonic dystonia
- Patients with suspected genetic movement disorders
Clinical Benefits of Genetic Testing
Undergoing the KCTD17 genetic test provides numerous advantages for patients and their families:
- Accurate Diagnosis: Confirms or rules out DYT26 myoclonic dystonia with high precision
- Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Prognostic Insights: Helps predict disease progression and potential complications
- Early Intervention: Facilitates timely management strategies for better outcomes
Understanding Your Test Results
Our comprehensive genetic report includes detailed interpretation of your results:
- Positive Result: Indicates the presence of a pathogenic KCTD17 mutation, confirming DYT26 diagnosis
- Negative Result: Suggests absence of known pathogenic variants in the KCTD17 gene
- Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications
- Carrier Status: Determines if you carry mutations that could affect future generations
All results are accompanied by detailed clinical interpretation and recommendations from our expert genetic counselors.
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.
Take Control of Your Neurological Health
Don’t let unexplained movement symptoms control your life. Our KCTD17 Gene DYT26 Myoclonic NGS Genetic DNA Test provides the clarity you need for proper diagnosis and management. With results available in 3-4 weeks and comprehensive genetic counseling support, you can make informed decisions about your neurological health.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic counseling team. Take the first step toward understanding your genetic profile and optimizing your treatment plan.
